Clover Health Investments, Corp.
CLOV- Exchange
- Nasdaq
- Industry
- Hospital & Medical Service Plans
- SEC CIK
- 0001801170
In the last 90 days, Clover Health Investments, Corp. insiders filed 0 open-market purchases and 18 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $762.6M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $4.61M in total
- 18
- 13F holdersQ2 2026, +20 vs. previous quarter
- 227
- 13F valueReported value at the end of Q2 2026
- $762.6M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding CLOV, Q2 2026
No superinvestor reported holding CLOV at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Clover Health Investments, Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 (view filing)4:22 PM ET | Sep 17 | 1 day | Reynoso Jamie L.CEO, Medicare Advantage | SSaleClass A Common Stock | −1.92K | $4.56 | −$8.76K | −0.1%2.80M after | 10b5-1 |
| Sep 17, 2026 (view filing)5:29 PM ET | Sep 16 | 1 day | Oldakowski Joseph FrankVP OF FINANCE AND CONTROLLER | SSaleClass A Common Stock | −3.17K | $4.64 | −$14.7K | −1.1%275.9K after | 10b5-1 |
| Sep 16, 2026 (view filing)4:27 PM ET | Sep 15 | 1 day | Wai ConradCEO, Counterpart Health | SSaleClass A Common Stock | −300.0K | $4.72 | −$1.42M | −20.4%1.17M after | 10b5-1 |
| Sep 15, 2026 (view filing)8:11 PM ET | Sep 15 | Same day | Soares KarenChief Legal Officer | SSaleClass A Common Stock | −6.85K | $4.78 | −$32.7K | −0.4%1.61M after | 10b5-1 |
| Sep 15, 2026 (view filing)7:48 PM ET | Sep 15 | Same day | Reynoso Jamie L.CEO, Medicare Advantage | SSaleClass A Common Stock | −9.27K | $4.78 | −$44.3K | −0.3%2.81M after | 10b5-1 |
| Sep 14, 2026 (view filing)8:52 PM ET | Sep 14 | Same day | Oldakowski Joseph FrankVP OF FINANCE AND CONTROLLER | SSaleClass A Common Stock | −20.0K | $5.16 | −$103.2K | −6.7%279.1K after | |
| Aug 17, 2026 (view filing)5:58 PM ET | Aug 17 | Same day | Thornton Joseph ClayInterim CFO | SSaleClass A Common Stock | −17.8K | $4.39 | −$78.0K | −1.4%1.25M after | 10b5-1 |
| Aug 10, 2026 (view filing)6:30 PM ET | Aug 10 | Same day | Toy AndrewChief Executive Officer | SSaleClass A Common Stock | −87.8K | $4.65 | −$408.3K | −0.9%9.46M after | 10b5-1 |
| Jul 20, 2026 (view filing)5:48 PM ET | Jul 20 | Same day | Soares KarenChief Legal Officer | SSaleClass A Common Stock | −51.7K | $4.51 | −$233.2K | −3.3%1.51M after | 10b5-1 |
| Jul 17, 2026 (view filing)5:26 PM ET | Jul 17 | Same day | Reynoso Jamie L.CEO, Medicare Advantage | SSaleClass A Common Stock | −4.84K | $4.53 | −$21.9K | −0.2%2.81M after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Clover Health Investments, Corp. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 35,106,965 | $184.0M | 0.00% | +3,266,453+10.3% | Added |
| Vanguard Capital Management LLC | 18,037,661 | $94.5M | 0.00% | +1,055,588+6.2% | Added |
| Geode Capital Management, LLC | 10,846,066 | $56.8M | 0.00% | +790,556+7.9% | Added |
| State Street Corp | 10,180,337 | $53.3M | 0.00% | +620,448+6.5% | Added |
| Nuveen, LLC | 6,291,699 | $33.0M | 0.01% | +5,356,156+572.5% | Added |
| Charles Schwab Investment Management Inc | 5,521,188 | $28.9M | 0.00% | +220,713+4.2% | Added |
| Vanguard Portfolio Management LLC | 4,470,452 | $23.4M | 0.00% | +774,015+20.9% | Added |
| Northern Trust Corp | 3,772,600 | $19.8M | 0.00% | +466,025+14.1% | Added |
| The PNC Financial Services Group, Inc. | 3,563,874 | $18.7M | 0.01% | −200,160−5.3% | Reduced |
| Dimensional Fund Advisors LP | 3,148,626 | $16.5M | 0.00% | −269,240−7.9% | Reduced |